Oregon oncologist hopes to offer broader access to new cancer therapy


CAR T cell therapy is a promising new gene therapy to treat cancer offered at a select few hospitals, including OHSU Hospital in Portland.

Medicare is considering whether to cover the pricey therapy, which is given for two types of blood cancers. A Eugene oncologist is hoping Medicare will soon cover CAR-T in both the outpatient and in-patient settings.

“The technology is evolving so quickly,” said Dr. Jeff Sharman, who also serves as medical director of hematology research for the US Oncology…

Previous The Motley Fool is putting together a hedge fund
Next UPMC says it won't deny access to Children's Hospital

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *